Zobrazeno 1 - 10
of 29
pro vyhledávání: ''
Autor:
Peter Kamper, Alexander Lindholm d'Amore, David W. Scott, Joseph M. Connors, Randy D. Gascoyne, Marcel Nijland, Sohrab P. Shah, Christian Steidl, Anja Mottok, Anke van den Berg, Stephen Hamilton-Dutoit, Fong Chun Chan, Alina S. Gerrie, Kerry J. Savage, Maryse M. Power, Arjan Diepstra, Francesco d'Amore
Publikováno v:
Chan, F C, Mottok, A, Gerrie, A S, Power, M, Nijland, M, Diepstra, A, van den Berg, A, Kamper, P, d'Amore, F, d'Amore, A L, Hamilton-Dutoit, S, Savage, K J, Shah, S P, Connors, J M, Gascoyne, R D, Scott, D W & Steidl, C 2017, ' Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma ', Journal of Clinical Oncology, vol. 35, no. 32, pp. 3722-3733 . https://doi.org/10.1200/JCO.2017.72.7925
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(32), 3722-3733. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(32), 3722-3733. AMER SOC CLINICAL ONCOLOGY
Purpose Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relapse and discover novel and robust biomarkers that predict outcomes after autologous stem-cell transplantation (ASCT). Materials and Methods We performed
Autor:
Gary A. Ulaner, Joshua Lilienstein, Andrew D. Zelenetz, Jocelyn C. Maragulia, Mithat Gonen, Craig H. Moskowitz
Publikováno v:
Journal of Clinical Oncology. 32:51-56
Purpose Determine the clinical significance of [18F]fluorodeoxyglucose (FDG)–avid lesions in patients with lymphoma treated with stem-cell transplantation. Methods All patients who underwent stem-cell transplantation for lymphoma at Memorial Sloan-
Autor:
Brenda J. Weigel, Pamela Jo Harris, Charlotte H. Ahern, Timothy P.L. Roberts, Ashish M. Ingle, Joel M. Reid, Sylvain Baruchel, Bing Wu, Julia L. Glade Bender, Alice Lee, Stephan D. Voss, Susan M. Blaney
Publikováno v:
Journal of Clinical Oncology. 31:3034-3043
Purpose Pazopanib, an oral multikinase angiogenesis inhibitor, prolongs progression-free survival in adults with soft tissue sarcoma (STS). A phase I pharmacokinetic and pharmacodynamic study of two formulations of pazopanib was performed in children
Autor:
Lars M. Wagner, Rochelle Bagatell, Clinton F. Stewart, Susan L. Cohn, Cynthia Kretschmar, Stephan D. Voss, Wendy B. London, John M. Maris
Publikováno v:
Journal of Clinical Oncology. 29:208-213
Purpose This phase II study was conducted to determine the response rate associated with use of irinotecan and temozolomide for children with relapsed/refractory neuroblastoma. Patients and Methods Patients with relapsed/refractory neuroblastoma meas
Autor:
David J. Straus, Daniel A. Filippa, Camelia Sima, Julie Teruya-Feldstein, James F. Caravelli, Carol S. Portlock, Heiko Schöder, Sarah A. Weaver, Alexia Iasonos, Ariela Noy, Steven M. Horwitz, Andrew D. Zelenetz, Craig H. Moskowitz, Owen A. O'Connor, Maria Lia Palomba, Jessica Meikle, Paul A. Hamlin
Publikováno v:
Journal of Clinical Oncology. 28:1896-1903
Purpose In studies of diffuse large B-cell lymphoma, positron emission tomography with [18F]fluorodeoxyglucose (FDG-PET) performed after two to four cycles of chemotherapy has demonstrated prognostic significance. However, some patients treated with
Autor:
Ingo G. Steffen, Stefan Schönberger, Holger Amthauer, Christian Furth, Daniel Misch, Timm Denecke, Juri Ruf, Brigitte Stöver, Günter Henze, Carsten Kobe, Hubertus Hautzel, Patrick Hundsdoerfer
Publikováno v:
Journal of Clinical Oncology. 27:4385-4391
Purpose In adult Hodgkin's lymphoma (HL) risk stratification after early therapy response assessment with [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) seems to allow tailoring therapy with less toxicity for patients with adequate
Autor:
Marjatta Lanning, Merja Möttönen, Arja Harila-Saari, Eija Pääkkö, Raija M. Seuri, Airi Jartti, Riitta Niinimäki, Pekka Riikonen
Publikováno v:
Journal of Clinical Oncology. 25:1498-1504
Purpose The aim of the study was to determine the incidence of and clinical risk factors for radiographic osteonecrosis (ON) in children treated for acute lymphoblastic leukemia (ALL) using the Nordic ALL protocols. Patients and Methods Ninety-seven
Autor:
Lisa Bomgaars, R. Klenke, J. R. Geyer, Jin-Hong Park, S. M. Blaney, J. Franklin, Naomi J. Winick, Gary V. Dahl, S. L. Berg
Publikováno v:
Journal of Clinical Oncology. 22:3916-3921
Purpose We performed a phase I trial of intrathecal (IT) liposomal cytarabine (DepoCyt; Enzon Pharmaceuticals, Piscataway, NJ and SkyePharma Inc, San Diego, CA) to determine the maximum-tolerated dose, the dose-limiting toxicities, and the plasma and
Publikováno v:
Journal of Clinical Oncology. 21:1082-1086
Purpose: The International Neuroblastoma Response Criteria (INRC) recommend, but do not make mandatory, metaiodobenzylguanidine (MIBG) scans. We present the first report on the effect of MIBG scans on the classification of response to dose-intensive
Autor:
Allan H. Friedman, Sandra Tourt-Uhlig, Nicholas Avgeropoulos, Valerie Stafford-Fox, Jeremy N. Rich, Darell D. Bigner, Brandon Evans, Roger E. McLendon, Henry S. Friedman, Jonathan L. Finlay, James E. Herndon, Sara L. Zaknoen, Mary Lou Affronti, Jennifer A. Quinn, David A. Reardon, John H. Sampson, Sridharan Gururangan, James M. Provenzale
Publikováno v:
Journal of Clinical Oncology. 21:646-651
Purpose: Temozolomide (Temodar; Schering-Plough Corp, Kenilworth, NJ) is an imidazole tetrazinone that undergoes chemical conversion to the active methylating agent 5-(3-methyltriazen-1yl)imidazole-4-carboximide under physiologic conditions. Previous